Process for preparing a pharmaceutically active compound (granisetron)

Suggestions

If you were to search for Process for preparing a pharmaceutically active compound (granisetron) using relaxed search criteria, these patents would come up:

Patent number     Title Issue date
6183783 Method for preparing microcapsules comprising active materials coated with a polymer and novel microcapsules in particular obtained according to the method 2001-02-06
6194005 Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix 2001-02-27
6221845 Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections 2001-04-24
6242497 Use of 6,7-substituted 2-aminotetralines suitable for preparing a pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies 2001-06-05
6252114 Process for preparing novel biologically active synthetic molecule 4-(p-methoxyphenyl)-2-amino-butane 2001-06-26
6258799 Aqueous coating composition and process for preparing solid pharmaceutical preparation 2001-07-10
6309815 Composition and method for preparation, storage and activation of large populations of immotile sperm 2001-10-30
6410794 Process for preparation of pharmaceutically desired chiral tetralone from tetralones 2002-06-25
6451729 Method for preparing a highly active, unsupported high surface-area MoS2 catalyst 2002-09-17
6455736 Process for preparation of pharmaceutically desired sertraline and sertraline analogs 2002-09-24
6458955 Process for preparation of pharmaceutically desired enantiomers 2002-10-01
6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation 2003-03-04
6534087 Process for preparing a pharmaceutical composition 2003-03-18
6602880 3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia 2003-08-05
6602988 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects 2003-08-05
6603129 Process for preparing rare earth activated alkaline earth metal fluorohalide stimulable phosphor particles 2003-08-05
6608055 Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition 2003-08-19
7071209 Process for preparing a pharmaceutically active compound (granisetron) 2006-07-04
7179489 Process for preparing a pharmaceutical composition containing an active ingredient and a micronised carrier/diluent 2007-02-20
7179913 Process for preparing a pharmaceutically active compound and for preparing its intermediate 2007-02-20
Claims:

The invention claimed is:

1. Process for preparing granisetron, or a pharmaceutically acceptable salt thereof, which comprises: a) cyclisation of a compound of formula (I): ##STR00007## in aninert solvent and at a temperature between 0 100.degree. C., in the presence of a strong acid, in order to yield the compound of formula (II): ##STR00008## b) methylation of the compound of formula (II), with an alkylating agent, in the presence of abase, in an inert solvent and at a temperature between 0.degree. C. 160.degree. C. and optionally obtaining a pharmaceutically acceptable salt thereof.

2. Process as claimed in claim 1, wherein step a) is carried out in a protic solvent or mixture of protic solvents.

3. Process as claimed in claim 1, wherein step a) is carried out at a temperature between 10.degree. C. and 40.degree. C.

4. Process as claimed in claim 1, wherein said alkylating agent is dimethyl sulphate.

5. Process as claimed in claim 1, wherein said alkylating agent is dimethyl carbonate.

6. Process as claimed in claim 1, wherein the solvent of step b) is selected from among methylene chloride, toluene or tetrahydrofuran.

7. Process as claimed in claim 1, wherein said base is sodium or potassium hydroxide in concentrated aqueous solution or in solid form.

8. Process as claimed in claim 1, wherein step b) is carried out in the presence of a phase transfer catalyst.

9. Process as claimed in claim 1, wherein the solvent of step b) is a polar aprotic solvent selected from either dimethylformamide (DMF) or N-methyl-2-pyrrolidonone (NMP).

10. Process as claimed in claim 1, wherein said base is an alkaline carbonate.

Patent number:
    7071209
View patent at USPTO

Filing date:
    March 21, 2003

Issue date:
    July 4, 2006

Inventors:
Pere Dalmases Barjoan (Sant Feliu de Llobregat, ES)
Salvador Puig Torres (Barcelona, ES)

Assignee:
Laboratorios Vita, S.A. (Sant Joan Despi, ES)

Primary Examiner:
Kamal A. Saeed

Attorney, Agent or Firm:
Wolf Block Schorr & Solis-Cohen LLP

Current U.S. Classification: 514/304 546/126

Email: contact@findthatpatent.com | © 2007 Dream Ratings | About

cool hit counter


example: magnesium alloy,  or: 6652852,  or: Jeffrey A. Ledbetter (inventor),  or whatever